Literature DB >> 12134957

Evaluation of capacity-limited first-pass effect through liver by three-points sampling in portal and hepatic veins and systemic artery.

Shinya Ueda1, Kiyoshi Yamaoka, Jyoji Yui, Akio Shigematsu, Terumichi Nakagawa.   

Abstract

PURPOSE: The three-points method was newly developed by sampling the portal and hepatic veins and systemic artery. A model of hepatic local disposition with the Michaelis-Menten elimination was proposed to explain the concentration dependency of the hepatic recovery ratio (F(H)).
METHODS: 5-fluorouracil (5-FU) was selected as a model drug. 5-FU was administered orally 90 min after its intraarterial dose. Blood specimens in both femoral artery and hepatic vein were sampled after intraarterial dose, and blood specimens in both femoral artery and portal vein were taken after oral administration.
RESULTS: It was shown that F(H) increased with an increase in the input drug concentration into the liver. The mean absorption time (MAT) estimated by nonlinear analysis agreed with the mean local absorption time (t(n)) whereas MAT by linear analysis was significantly smaller than t(a).
CONCLUSIONS: The three-points method was newly developed, and the proposed nonlinear model explained well the capacity-limited elimination of 5-FU through the liver. MAT by the nonlinear analysis was in good agreement with t(a).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134957     DOI: 10.1023/a:1016165101921

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Circadian variation of 5-fluorouracil catabolism in isolated perfused rat liver.

Authors:  B E Harris; R L Song; S J Soong; R B Diasio
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

Review 2.  Oral bioavailability and first-pass effects.

Authors:  K C Kwan
Journal:  Drug Metab Dispos       Date:  1997-12       Impact factor: 3.922

3.  Short-period double-dosing for simultaneous evaluation of intestinal absorption and hepatic disposition in a single conscious rat using cephalexin as test drug.

Authors:  T Ito; K Yamaoka; T Nakagawa
Journal:  J Pharm Pharmacol       Date:  1997-12       Impact factor: 3.765

4.  Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measure.

Authors:  R F Frye; A Adedoyin; K Mauro; G R Matzke; R A Branch
Journal:  J Clin Pharmacol       Date:  1998-01       Impact factor: 3.126

5.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

6.  Carrier-mediated hepatic uptake of the cationic cyclopeptide, octreotide, in rats. Comparison between in vivo and in vitro.

Authors:  T Yamada; K Niinuma; M Lemaire; T Terasaki; Y Sugiyama
Journal:  Drug Metab Dispos       Date:  1997-05       Impact factor: 3.922

7.  Effect of pentobarbital anaesthesia on intestinal absorption and hepatic first-pass metabolism of oxacillin in rats, evaluated by portal-systemic concentration difference.

Authors:  S Ueda; K Yamaoka; T Nakagawa
Journal:  J Pharm Pharmacol       Date:  1999-05       Impact factor: 3.765

8.  Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil.

Authors:  H Nakayama; T Kinouchi; K Kataoka; S Akimoto; Y Matsuda; Y Ohnishi
Journal:  Pharmacogenetics       Date:  1997-02

9.  Distribution volume of three 99mTc-labeled compounds in the rat liver with time after intraportal and intravenous injections.

Authors:  J Nishigaki; S Suzuki; J Yui; A Shigematsu
Journal:  Biol Pharm Bull       Date:  1995-12       Impact factor: 2.233

10.  Evaluation of intestinal absorption into the portal system in enterohepatic circulation by measuring the difference in portal-venous blood concentrations of diclofenac.

Authors:  K Tabata; K Yamaoka; T Fukuyama; T Nakagawa
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

View more
  2 in total

1.  Mean hepatic recovery ratio in capacity-limited first-pass effect by three-point sampling method.

Authors:  Mitsuo Higashimori; Kiyoshi Yamaoka
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-08       Impact factor: 2.745

2.  Metallokinetic characteristics of antidiabetic bis(allixinato)oxovanadium(IV)-related complexes in the blood of rat.

Authors:  Hiroyuki Yasui; Yusuke Adachi; Akira Katoh; Hiromu Sakurai
Journal:  J Biol Inorg Chem       Date:  2007-05-15       Impact factor: 3.358

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.